Oct 25, 2019 - AbbVie's (ABBV) Q3 sales may have been weighed down by biosimilar competition for Humira in international markets. However, strong growth of oncology drugs might have offset impact of Humira's international sales erosion.
Oct 25, 2019 - AbbVie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Oct 22, 2019 - Biogen (BIIB) beats estimates for both earnings and sales in the third quarter. It is set to pursue FDA approval of aducanumab. Shares skyrocket in pre-market trading.
Oct 21, 2019 - With earnings surprise in the cards, the healthcare sector is expected to witness modest earnings growth of 0.3% in the third quarter, suggesting some room for potential upside for healthcare ETFs.
Oct 20, 2019 - These solid companies have boosted their dividends by at least 67% over the last three years.
Oct 17, 2019 - Novartis' (NVS) phase III REACH2 study on Jakavi for treating patients with steroid-refractory acute graft-versus-host disease meets the primary endpoint of superior overall response rate.
Oct 17, 2019 - Top Ranked Income Stocks to Buy for October 17th
Oct 16, 2019 - The company reclaimed rights to several promising drug candidates last week; this week, positive data from a pivotal clinical trial sent it soaring.
Oct 16, 2019 - AbbVie (ABBV) possesses solid growth attributes, which could help it handily outperform the market.
Oct 16, 2019 - Top Ranked Momentum Stocks to Buy for October 16th